Adenovirus (Blend) Coating Antibody, clone 2/6, and 20/11 | EMD Millipore MAB805 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

EMD Millipore

other brands :

Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava

product type :

antibody

product name :

Adenovirus (Blend) Coating Antibody, clone 2/6, and 20/11

catalog :

MAB805

quantity :

100 μL

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

2/6, and 20/11

reactivity :

unidentified adenovirus

application :

immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section

citations: 18

Published Application/Species/Sample/Dilution	Reference
immunocytochemistry; unidentified adenovirus; 10 ug/mL	Crotti T, Dharmapatni A, Alias E, Zannettino A, Smith M, Haynes D. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints. Arthritis Res Ther. 2012;14:R245 pubmed publisher
	Shen Y, Yang F, Wang H, Cai Z, Xu Y, Zhao A, et al. Arg-Gly-Asp (RGD)-Modified E1A/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in Mice. PLoS ONE. 2016;11:e0147173 pubmed publisher
	Lachiewicz A, Cianciolo R, Miller M, Derebail V. Adenovirus causing fever, upper respiratory infection, and allograft nephritis complicated by persistent asymptomatic viremia. Transpl Infect Dis. 2014;16:648-52 pubmed publisher
	Wang H, Cai Z, Yang F, Luo J, Satoh M, Arai Y, et al. Enhanced antitumor efficacy of integrin-targeted oncolytic adenovirus AxdAdB3-F/RGD on bladder cancer. Urology. 2014;83:508.e13-9 pubmed publisher
	Santos G, Parra E, Stegun F, Cirqueira C, Capelozzi V. Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation. Braz J Med Biol Res. 2013;46:985-992 pubmed
	Liu R, Peng J, Li Y, Huang B, Lin H, Zhou L, et al. Tumor-specific cytolysis caused by an E1B55K-attenuated adenovirus in nasopharyngeal carcinoma is augmented by cisplatin. Anat Rec (Hoboken). 2013;296:1833-41 pubmed publisher
	Li L, Zhang Y, Zhou L, Ke M, Chen J, Fu X, et al. Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells. J Transl Med. 2013;11:257 pubmed publisher
	Bazan Peregrino M, Sainson R, Carlisle R, Thoma C, Waters R, Arvanitis C, et al. Combining virotherapy and angiotherapy for the treatment of breast cancer. Cancer Gene Ther. 2013;20:461-8 pubmed publisher
	Ueda K, Kawabata R, Irie T, Nakai Y, Tohya Y, Sakaguchi T. Inactivation of pathogenic viruses by plant-derived tannins: strong effects of extracts from persimmon (Diospyros kaki) on a broad range of viruses. PLoS ONE. 2013;8:e55343 pubmed publisher
	Magin W, Van Kruiningen H, Colombel J. Immunohistochemical search for viral and bacterial antigens in Crohn's disease. J Crohns Colitis. 2013;7:161-6 pubmed publisher
	Hidalgo M, Miranda J, Heredia D, Zambrano P, Vesga J, Lizarazo D, et al. Outbreak of Rocky Mountain spotted fever in Córdoba, Colombia. Mem Inst Oswaldo Cruz. 2011;106:117-8 pubmed
	Treacy A, Carr M, Dunford L, Palacios G, Cannon G, O Grady A, et al. First report of sudden death due to myocarditis caused by adenovirus serotype 3. J Clin Microbiol. 2010;48:642-5 pubmed publisher
	Bazan Peregrino M, Carlisle R, Hernandez Alcoceba R, Iggo R, Homicsko K, Fisher K, et al. Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus. Hum Gene Ther. 2008;19:873-86 pubmed publisher
	Satoh M, Wang H, Ishidoya S, Abe H, Moriya T, Hamada H, et al. Oncolytic virotherapy for prostate cancer by E1A, E1B mutant adenovirus. Urology. 2007;70:1243-8 pubmed
	Post D, Sandberg E, Kyle M, Devi N, Brat D, Xu Z, et al. Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4. Cancer Res. 2007;67:6872-81 pubmed
	Perez D, McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Clavien P. Successful outcome of severe adenovirus hepatitis of the allograft following liver transplantation. Transpl Infect Dis. 2007;9:318-22 pubmed
	Chung Y, Kim M, Lee W, Kang C. Silencing E1A mRNA by RNA interference inhibits adenovirus replication. Arch Virol. 2007;152:1305-14 pubmed
	Wang H, Satoh M, Abe H, Sunamura M, Moriya T, Ishidoya S, et al. Oncolytic viral therapy by bladder instillation using an E1A, E1B double-restricted adenovirus in an orthotopic bladder cancer model. Urology. 2006;68:674-81 pubmed

product information

Catalog Number :

MAB805

Subcategory :

Infectious Diseases

Product Name :

Anti-Adenovirus (Blend) Coating Antibody, clone 2/6, and 20/11

Product Type :

Antibodies

Clonality :

Monoclonal Antibody

Host Name :

Mouse

Antigen :

Adenovirus (Blend) Coating

Clone :

2/6, and 20/11

Conjugate :

Ascites

Isotype :

IgG1κ

Product Description :

Anti-Adenovirus (Blend) Coating Antibody, clone 2/6, and 20/11

Cross Reactivity :

Human

Background :

Adenoviruses are 65-80 nm, non-enveloped, regular icosahedron pathogens often associated with respiratory and gastrointestinal illness as well as conjunctivitis. Well over 40 types of adenoviruses have currently been recognized. In addition to their deleterious effects, adenoviruses have been used in vaccine production and in gene therapy. They also have the ability to trigger cell proliferation by interfering with host cellular anti-oncogenes. Since they are easy to prepare, multiple quickly and efficiently, and have the ability to infect and deliver their genome (including researcher-created constructs) to the nucleus of a variety of post-mitotic cells, adenoviruses are extremely valuable in research and medical applications ranging from virus/host cell interaction to the insertion of novel genes or regulatory mechanisms into eukaryotic cellular systems, to delivery of therapeutic anti-cancer genes.

Immunogen :

Adeno 3

Specificity :

Reactive with all 41 serotypes of Adenovirus.

Package Size :

100 μL

Uses :

ELISA;Immunofluorescence;Immunohistochemistry;Immunohistochemistry (Paraffin)

Storage :

Maintain for 1 year at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.